I en undersøgelse med gentagne doser på voksne patienter med seglcellesygdom blev cirka 60% af hydroxycarbamid- dosis konstateret i urin ved steady state.
In a repeated dose study in adult patients with Sickle Cell Syndrome approximately 60% of the hydroxycarbamide dose was detected in urine at steady state.